Thanks.

-----Original Message-----
From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Charlie Hathaway
Sent: Thursday, September 16, 2010 10:32 AM
To: xxxxxx@hrinet.org
Subject: Re: [RESADM-L] Quick Question on NIH Page Limits

absolutely (remember 6 + 1 for Spec Aims)

and the Intro is only ONE PAGE for an R21

it was WORSE for all the R01 people who had to go from 25 to 13 on hteir
resubmissions

CH

> Dear All,
>
> My question pertains to A2 submissions of R21 NIH proposal applications.
> The initial and A1 applications were submitted under the old page
> allowance format.  Are you advising your faculty to use the new 6 page
> limit for their A2 submissions?
>
>
> Your responses appreciated.
>
> Thanks.
>
> Valerie
>
> Valerie A. Blake
> Director
> Office of Grants and Contracts
> Feinstein Institute for Medical Research
> North Shore-Long Island Jewish Health System
>
> 350 Community Drive
> Manhasset, NY 11030
> Phone:  (516) 562-3106
> Fax:  (516) 562-3107
> Email:  xxxxxx@nshs.edu
>
>
>
> ======================================================================
>  Instructions on how to use the RESADM-L Mailing List, including
>  subscription information and a web-searchable archive, are available
>  via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================